Cargando…

Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy

Tendon disorders include tenosynovitis or tendonitis, tendinosis, and tendon rupture. Tendinopathy associated with drug administration has been associated with the systemic or local administration of several medications. A 90-year-old man who developed toxic tendinopathy after receiving cephalexin 5...

Descripción completa

Detalles Bibliográficos
Autor principal: Cohen, Philip R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433089/
https://www.ncbi.nlm.nih.gov/pubmed/30915263
http://dx.doi.org/10.7759/cureus.3783
_version_ 1783406244777689088
author Cohen, Philip R
author_facet Cohen, Philip R
author_sort Cohen, Philip R
collection PubMed
description Tendon disorders include tenosynovitis or tendonitis, tendinosis, and tendon rupture. Tendinopathy associated with drug administration has been associated with the systemic or local administration of several medications. A 90-year-old man who developed toxic tendinopathy after receiving cephalexin 500 mg twice daily has been described. Unilateral pain of his left Achilles tendon pain during walking appeared three weeks after starting the antibiotic. The drug was stopped after four weeks of treatment; within one week after discontinuing the cephalexin, all tendonitis symptoms spontaneously resolved. Drug-induced tendinopathy has most commonly been associated with fluoroquinolones, statins, glucocorticoids, and aromatase inhibitors. In addition, other systemic agents have caused tendinopathy; they include amlodipine, anabolic steroids, antiretrovirals, isotretinoin, renin-angiotensin II receptor antagonists, rituximab, and sitagliptin. Albeit less frequent, other oral antibiotics, including cephalosporins, azithromycin, and sulfonamides, have also been associated with toxic tendinopathy. Also, injections of collagenase Clostridium histolyticum, corticosteroids, and polidocanol have been followed by tendon rupture. The features of tendinopathy associated with drug treatment are summarized and their postulated mechanisms of pathogenesis are reviewed. The onset of tendon pain following the initiation of treatment with a new medication, especially if the agent has previously been associated with drug-induced tendonitis, tendinosis, or tendon rupture, should prompt the consideration of drug-associated toxic tendinopathy.
format Online
Article
Text
id pubmed-6433089
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-64330892019-03-26 Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy Cohen, Philip R Cureus Dermatology Tendon disorders include tenosynovitis or tendonitis, tendinosis, and tendon rupture. Tendinopathy associated with drug administration has been associated with the systemic or local administration of several medications. A 90-year-old man who developed toxic tendinopathy after receiving cephalexin 500 mg twice daily has been described. Unilateral pain of his left Achilles tendon pain during walking appeared three weeks after starting the antibiotic. The drug was stopped after four weeks of treatment; within one week after discontinuing the cephalexin, all tendonitis symptoms spontaneously resolved. Drug-induced tendinopathy has most commonly been associated with fluoroquinolones, statins, glucocorticoids, and aromatase inhibitors. In addition, other systemic agents have caused tendinopathy; they include amlodipine, anabolic steroids, antiretrovirals, isotretinoin, renin-angiotensin II receptor antagonists, rituximab, and sitagliptin. Albeit less frequent, other oral antibiotics, including cephalosporins, azithromycin, and sulfonamides, have also been associated with toxic tendinopathy. Also, injections of collagenase Clostridium histolyticum, corticosteroids, and polidocanol have been followed by tendon rupture. The features of tendinopathy associated with drug treatment are summarized and their postulated mechanisms of pathogenesis are reviewed. The onset of tendon pain following the initiation of treatment with a new medication, especially if the agent has previously been associated with drug-induced tendonitis, tendinosis, or tendon rupture, should prompt the consideration of drug-associated toxic tendinopathy. Cureus 2018-12-27 /pmc/articles/PMC6433089/ /pubmed/30915263 http://dx.doi.org/10.7759/cureus.3783 Text en Copyright © 2018, Cohen et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Cohen, Philip R
Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy
title Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy
title_full Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy
title_fullStr Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy
title_full_unstemmed Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy
title_short Cephalexin-associated Achilles Tendonitis: Case Report and Review of Drug-induced Tendinopathy
title_sort cephalexin-associated achilles tendonitis: case report and review of drug-induced tendinopathy
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433089/
https://www.ncbi.nlm.nih.gov/pubmed/30915263
http://dx.doi.org/10.7759/cureus.3783
work_keys_str_mv AT cohenphilipr cephalexinassociatedachillestendonitiscasereportandreviewofdruginducedtendinopathy